Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
- 1 May 2009
- journal article
- research article
- Published by Annals of Family Medicine in Annals of Family Medicine
- Vol. 7 (3) , 212-222
- https://doi.org/10.1370/afm.942
Abstract
PURPOSE Multiple cancer screening tests have been advocated for the general population; however, clinicians and patients are not always well-informed of screening burdens. We sought to determine the cumulative risk of a false-positive screening result and the resulting risk of a diagnostic procedure for an individual participating in a multimodal cancer screening program. METHODS Data were analyzed from the intervention arm of the ongoing Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, a randomized controlled trial to determine the effects of prostate, lung, colorectal, and ovarian cancer screening on disease-specific mortality. The 68,436 participants, aged 55 to 74 years, were randomized to screening or usual care. Women received serial serum tests to detect cancer antigen 125 (CA-125), transvaginal sonograms, posteroanterior-view chest radiographs, and flexible sigmoidoscopies. Men received serial chest radiographs, flexible sigmoidoscopies, digital rectal examinations, and serum prostate-specific antigen tests. Fourteen screening examinations for each sex were possible during the 3-year screening period. After 14 tests, the cumulative risk of having at least I false-positive screening test is 60.4% (95% Cl, 59.8%-61.0%) for men, and 48.8% (95% CI, 48.1%-49.4%) for women. The cumulative risk after 14 tests of undergoing an invasive diagnostic procedure prompted by a false-positive test is 28.5% (Cl, 27.8%-29.3%) for men and 22.1% (95% Cl, 21.4%-22.7%) for women. CONCLUSIONS For an individual in a multimodal cancer screening trial, the risk of a false-positive finding is about 50% or greater by the 14th test. Physicians should educate patients about the likelihood of false positives and resulting diagnostic interventions when counseling about cancer screening. Ann Fam Med 2009;7:212-222. DOI: 10.1370/afm.942.Keywords
This publication has 28 references indexed in Scilit:
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyCA: A Cancer Journal for Clinicians, 2008
- Lead time associated with screening for prostate cancerInternational Journal of Cancer, 2003
- Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.JNCI Journal of the National Cancer Institute, 2002
- Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trialThe Lancet, 2002
- The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and statusPublished by Elsevier ,2001
- Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialPublished by Elsevier ,2001
- Coordination and management of a large multicenter screening trial: The prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Design and evolution of the data management systems in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Quality control of cancer screening examination procedures in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Ovarian Volume Related to AgeGynecologic Oncology, 2000